Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

368 trials with published results (14%)

Research Maturity

1405 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.9%

185 terminated out of 2690 trials

Success Rate

88.4%

+1.8% vs benchmark

Late-Stage Pipeline

17%

452 trials in Phase 3/4

Results Transparency

26%

368 of 1405 completed with results

Key Signals

368 with results88% success185 terminated

Data Visualizations

Phase Distribution

1,644Total
Not Applicable (1040)
Early P 1 (4)
P 1 (39)
P 2 (109)
P 3 (185)
P 4 (267)

Trial Status

Completed1,405
Unknown521
Recruiting276
Terminated185
Active Not Recruiting111
Not Yet Recruiting88

Trial Success Rate

88.4%

Benchmark: 86.6%

Based on 1405 completed trials

Clinical Trials (2690)

Showing 20 of 20 trials
NCT06280768Phase 1CompletedPrimary

Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation

NCT06521463Not ApplicableActive Not RecruitingPrimary

SIMPLAAFY Clinical Trial

NCT04907825Phase 4CompletedPrimary

A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF

NCT07752758Phase 4Not Yet RecruitingPrimary

Ezetimibe for Arrhythmia Recurrence After AF Ablation

NCT06223789Not ApplicableCompleted

VOLT-AF IDE Clinical Study

NCT07523750Not ApplicableRecruitingPrimary

A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

NCT07139301Not ApplicableRecruiting

Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation

NCT04394546Not ApplicableActive Not RecruitingPrimary

CHAMPION-AF Clinical Trial

NCT05159492Not ApplicableCompletedPrimary

Ground-Breaking Electroporation-based Intervention for PAROXysmal Atrial Fibrillation Treatment (BEAT PAROX-AF)

NCT07741682Not ApplicableCompletedPrimary

The Effect of an Intervention Based on The CSM on Self-Management in Patients After Atrial Fibrillation Ablation

NCT07081711Recruiting

Longitudinal Validation of CIRC Technologies

NCT07511166Not Yet RecruitingPrimary

A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation

NCT07527299Not ApplicableRecruitingPrimary

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

NCT07217067Phase 2RecruitingPrimary

A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

NCT07227532Not ApplicableRecruitingPrimary

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

NCT07625215Phase 2Not Yet RecruitingPrimary

A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation

NCT05378035RecruitingPrimary

DOAC in Chinese Patients With Atrial Fibrillation

NCT07270211Not Yet RecruitingPrimary

MCG In Long QT Syndrome

NCT07492498Not ApplicableRecruitingPrimary

Novel Model of Integrated Care of Older Patients With Atrial Fibrillation to Prevent Heart Failure in Rural China

NCT06808217Active Not RecruitingPrimary

A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation

Scroll to load more

Research Network

Activity Timeline